AI in Cardiology Market Growth, Innovations and Market Size Forecast 2035
Forecasts suggest that the AI in cardiology market will expand from USD 3.44 billion in 2026 to USD 49.16 billion by 2035, with a CAGR of 34.38% during this period. AI in cardiology refers to the use of artificial intelligence to analyze heart-related data, assist in diagnosing conditions, predict risks, and improve treatments. It helps doctors detect heart diseases early, interpret ECGs and imaging, and personalize patient care, making heart healthcare faster, more accurate, and efficient.
Last Updated : 04 August 2026Category: Healthcare ITInsight Code: 5077Format: PDF / PPT / Excel
Regulatory Framework for Leading Countries/Regions
Supply Demand Analysis
Production & Consumption Statistics
Export Import Statistics
Price Trend Analysis
Global AI in Cardiology Market Assessment
Overview
Global AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
Hardware
Software
Services
Global AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
Cardiac Arrhythmias
Stroke
Ischemic Heart Disease/CAD
Others
Global AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa (MEA)
North America AI in Cardiology Market Assessment
Overview
North America AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
Hardware
Software
Services
North America AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
Cardiac Arrhythmias
Stroke
Ischemic Heart Disease/CAD
Others
Europe AI in Cardiology Market Assessment
Overview
Europe AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
Hardware
Software
Services
Europe AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
Cardiac Arrhythmias
Stroke
Ischemic Heart Disease/CAD
Others
Asia-Pacific AI in Cardiology Market Assessment
Overview
Asia-Pacific AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
Hardware
Software
Services
Asia-Pacific AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
Cardiac Arrhythmias
Stroke
Ischemic Heart Disease/CAD
Others
Latin America AI in Cardiology Market Assessment
Overview
Latin America AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
Hardware
Software
Services
Latin America AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
Cardiac Arrhythmias
Stroke
Ischemic Heart Disease/CAD
Others
Middle East & Africa (MEA) AI in Cardiology Market Assessment
Overview
Middle East & Africa (MEA) AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Component (2021 – 2033)
Hardware
Software
Services
Middle East & Africa (MEA) AI in Cardiology Market Size Value (US$) and Volume (Billion Tons), by Application (2021 – 2033)
Cardiac Arrhythmias
Stroke
Ischemic Heart Disease/CAD
Others
Company Profiles
Philips
Company Overview
Geographic Footprints
Financial Performance
Product Portfolio
SWOT Analysis
R&D Efforts
Recent Developments & Strategic Collaborations
Product Launch/M&A/Technical Collaboration
Siemens Healthineers
Medtronic Johnson & Johnson
Google Health
Microsoft Healthcare
Ultromics Limited
CardiAl I
IBM Watson Health
IDOVEN
Conclusion & Recommendations
FAQ's
Answer : AI in cardiology market stands at USD 3.44 billion in 2026 and is expected to reach USD 49.16 billion by 2035, growing at a CAGR of 34.38% from 2026 to 2035.
Answer : The North America dominate globally is expected to see a 41 percent increase in heart disease related medical costs between 2010 and 2040, from USD 126.2 billion to USD 177.5 billion. Some of the factors driving this upward trend include the regions expanding number of new artificial intelligence product approvals by regulators, a strong healthcare system and the rapid adoption of cutting edge products.
Answer : World Health Organisation, Food and Drug Administration, National Institute of Health, European Parliamentary Research Service, American College of Cardiology Foundation, British Heart Foundation, Center for Disease Control and Prevension.
Payal Rabde is a Healthcare Market Research Analyst at Towards Healthcare Research & Consulting with 4+ years of experience in pharmaceuticals, biotechnology, medical devices, and life sciences.
Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare
market research. As a content reviewer, Aditi ensures the quality and accuracy of all market
insights and data presented by the research team.
We use cookies that are necessary to make our site work. We may also use additional cookies to analyze,
improve, and personalize our content and your digital experience.
You can manage your cookie preferences using the
Privacy Policy
For more information, see our
Terms and Conditions
.
Cookie Preference Center
We use cookies which are necessary to make our site work.
We may also use additional cookies to analyze, improve and personalize
our content and your digital experience.
For more information, please read our
Cookie Policy
.
You may choose not to allow some types of cookies.
Blocking some cookies may impact your experience of the site.
sales@towardshealthcare.com
+1 804-441-9344
Download Sample
USA : +1 8044 419344
sales@towardshealthcare.com